Chapter Charts
If you find any inaccurate information, please let us know by providing your feedback here
Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
The lists that follow are intended to be a guide to the chapters in this publication. They may not be all-inclusive, and they are not intended to describe expectations for articles or limit the application of tests to any article in the USP–NF.
1 Official Articles
Non-Complex Drug Substances
Biotechnology-Derived Drug Substances Excipients
Non-Complex Active Drug Products
Biotechnology-Derived Drug Products Vaccines
Blood and Blood Products
Gene and Cell Therapy Products Dietary Supplement Ingredients Dietary Supplement Products
Compounding—Substance/Preparation/Practice Medical Devices
2 Generally Applicable
Basic Elements
〈1010〉 Analytical Data—Interpretation and Treatment
〈1029〉 Good Documentation Guidelines
〈1039〉 Chemometrics
〈1058〉 Analytical Instrument Qualification
〈1097〉 Bulk Powder Sampling Procedures
〈1149〉 Guidelines for Assessing and Controlling the Physical Stability of Chemical and Biological Pharmaceutical Raw Materials, Intermediates, and Dosage Forms
〈1151〉 Pharmaceutical Dosage Forms
〈1153〉 Drug Products Containing Nanomaterials 〈1210〉 Statistical Tools for Procedure Validation 〈1220〉 Analytical Procedure Life Cycle
〈1225〉 Validation of Compendial Procedures
〈1226〉 Verification of Compendial Procedures
Drug Product Distribution
Microbiology Products
